Expanding CDMO Capabilities Laboratorios Alcala Farma’s versatile manufacturing infrastructure and GMP-certified facilities enable it to produce a wide range of pharmaceutical forms, presenting opportunities to collaborate on diverse projects and innovative drug formulations across various formats including liquids, solids, and sterile products.

Growth through Acquisition As part of the Synerlab Group, Alcala Farma has a strategic backing that can facilitate joint ventures, technology transfers, or co-development agreements, especially for companies seeking European manufacturing solutions with a focus on quality and regulatory compliance.

Strong R&D Expertise With a dedicated research and development team specializing in proprietary product development, reformulation, and regulatory dossier preparation, there is a potential for partnerships in new product innovation or updates to existing product lines.

Market Focus and Certifications Alcala Farma’s focus on OTC, Food Supplements, and sterile products, combined with its compliance with European and non-European standards, makes it an ideal partner for companies targeting expansion into regulated markets with high-quality manufacturing requirements.

Growth Potential With annual revenue between $10 million and $25 million and recent acquisition backing, Alcala Farma is positioned for further expansion and could be a strategic partner for companies seeking to scale production and access European markets through a reliable CDMO partner.